Venous Thromboembolism Diagnosis and Management
Venous Thromboembolism Diagnosis and Management is a research topic within Internal Medicine. Science Explorer counts 74k research works in it since 1950. 13.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the prevention, diagnosis, and treatment of venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. It covers various aspects such as antithrombotic therapy, risk factors, prophylaxis, and management in patients with cancer. The cluster also discusses the development of clinical practice guidelines for VTE.
- Venous Thromboembolism
- Antithrombotic Therapy
- Pulmonary Embolism
- Deep Vein Thrombosis
- Cancer-Associated Thrombosis
- Prophylaxis
- Risk Factors
- Diagnosis
- Treatment
- Clinical Practice Guidelines
- Research works
- 74k fractional, since 1950
- In the world top 10%
- 9.8k per year above
- Top-10% rate
- 13.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +30% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Venous Thromboembolism Diagnosis and Management research?
By volume, the United States and China publish the most (3.7k and 1.5k works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.7k works
- 2 China 1.5k works
- 3 United Kingdom 554 works
- 4 Japan 547 works
- 5 Italy 472 works
- 6 India 463 works
- 7 Germany 454 works
- 8 Spain 392 works
- 9 Türkiye 387 works
- 10 France 368 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Venous Thromboembolism Diagnosis and Management research?
By volume in 2022–2025, Massachusetts General Hospital publishes the most Venous Thromboembolism Diagnosis and Management research, followed by Cleveland Clinic and Harvard University.
By volume, 2022–2025
- 1 Massachusetts General Hospital United States 50 works
- 2 Cleveland Clinic United States 47 works
- 3 Harvard University United States 46 works
- 4 University of North Carolina at Chapel Hill United States 44 works
- 5 Yale University United States 40 works
- 6 Capital Medical University China 38 works
- 7 Brigham and Women's Hospital United States 37 works
- 8 Chinese Academy of Medical Sciences & Peking Union Medical College China 36 works
- 9 Sağlık Bilimleri Üniversitesi Türkiye 36 works
- 10 Mayo Clinic in Arizona United States 34 works
Who are the leading researchers in Venous Thromboembolism Diagnosis and Management?
The most-cited researchers publishing on Venous Thromboembolism Diagnosis and Management include Elie A. Akl, Patrick M. Bossuyt and Graeme J. Hankey.
- 1 Elie A. Akl 18k citations
- 2 Patrick M. Bossuyt 14k citations
- 3 Graeme J. Hankey 7.2k citations
- 4 Gordon Guyatt 6.8k citations
- 5 Valentı́n Fuster 5.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Venous Thromboembolism Diagnosis and Management research done?
The largest centres of Venous Thromboembolism Diagnosis and Management research in 2022–2025 are Beijing (China), New York (United States), London (United Kingdom) and Boston (United States).
Largest cities, 2022–2025
Where is the best place to study Venous Thromboembolism Diagnosis and Management?
Among universities, judged by research, Victor Babeș University of Medicine and Pharmacy Timișoara, Pirogov Russian National Research Medical University and Medical University of Vienna score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Victor Babeș University of Medicine and Pharmacy Timișoara Romania | 65.8 | 48.0% | 7.7× | 9 | +322.9% |
| 2 | Pirogov Russian National Research Medical University Russia | 60.1 | 5.0% | 15.2× | 33 | +490.4% |
| 3 | Medical University of Vienna Austria | 54.9 | 21.9% | 8.0× | 30 | -11.5% |
| 4 | Johannes Gutenberg University Mainz Germany | 51.3 | 29.6% | 4.9× | 18 | +89.9% |
| 5 | Harvard University United States | 48.6 | 21.5% | 3.0× | 46 | +34.5% |
| 6 | Icahn School of Medicine at Mount Sinai United States | 48.2 | 8.6% | 5.5× | 33 | +144.5% |
| 7 | University of Ottawa Canada | 47.9 | 22.8% | 3.5× | 22 | +124.8% |
| 8 | Medical University of Warsaw Poland | 47.4 | 19.7% | 7.0× | 19 | +66.9% |
| 9 | Capital Medical University China | 46.7 | 14.1% | 5.4× | 38 | +65.7% |
| 10 | Yale University United States | 46.6 | 13.9% | 3.3× | 40 | +121.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Venous Thromboembolism Diagnosis and Management research growing?
Output in 2018–2022 was 30% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Venous Thromboembolism Diagnosis and Management.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.